April 1st, 20210BALTIMORE — A mix-up of dosages at a Baltimore production facility has prompted the FDA to delay certification of the facility and ruined 15 million doses of the COVID vaccine.
Employees at Emergent BioSolutions, a manufacturing partner to Johnson & Johnson and AstraZeneca, reportedly mixed-up two dosages of the vaccine and the...